The emerging role of DOT1L in cell proliferation and differentiation: Friend or foe.

Cell proliferation and differentiation are the basic physiological activities of cells. Mistakes in these processes may affect cell survival, or cause cell cycle dysregulation, such as tumorigenesis, birth defects and degenerative diseases. In recent years, it has been found that histone methyltransferase DOT1L is the only H3 lysine 79 methyltransferase, which plays an important role in the process of cell fate determination through monomethylation, dimethylation and trimethylation of H3K79. DOT1L has a pro-proliferative effect in leukemia cells; however, loss of heart-specific DOT1L leads to increased proliferation of cardiac tissue. Additionally, DOT1L has carcinogenic or tumor suppressive effects in different neoplasms. At present, some DOT1L inhibitors for the treatment of MLL-driven leukemia have achieved promising results in clinical trials, but completely blocking DOT1L will also bring some side effects. Thus, this uncertainty suggests that DOT1L has a unique function in cell physiology. In this review, we summarize the primary findings of DOT1L in regulating cell proliferation and differentiation. Correlations between DOT1L and cell fate specification might suggest DOT1L as a therapeutic target for diseases.

[1]  R. R. Reijo Pera,et al.  Identification of DOT1L inhibitor in a screen for factors that promote dopaminergic neuron survival , 2022, Frontiers in Aging Neuroscience.

[2]  Wei Wei,et al.  PU.1 promotes development of rheumatoid arthritis via repressing FLT3 in macrophages and fibroblast-like synoviocytes , 2022, Annals of the Rheumatic Diseases.

[3]  Fatih Kocabaş,et al.  The Historical Relationship Between Meis1 and Leukemia. , 2022, Advances in experimental medicine and biology.

[4]  G. Condorelli,et al.  The epigenetic enzyme DOT1L orchestrates vascular smooth muscle cell-monocyte crosstalk and protects against atherosclerosis via the NF-κB pathway. , 2022, European heart journal.

[5]  Derek J Van Booven,et al.  DOT1L Is a Novel Cancer Stem Cell Target for Triple-Negative Breast Cancer , 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  L. Casas-Fraile,et al.  Hypoxia induces DOT1L in articular cartilage to protect against osteoarthritis , 2021, JCI insight.

[7]  A. Grishok,et al.  Faculty Opinions recommendation of DOT1L O-GlcNAcylation promotes its protein stability and MLL-fusion leukemia cell proliferation. , 2021, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[8]  Romi Gupta,et al.  Disruptor of telomeric silencing 1-like promotes ovarian cancer tumor growth by stimulating pro-tumorigenic metabolic pathways and blocking apoptosis , 2021, Oncogenesis.

[9]  J. Cortes,et al.  CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a randomised, open-label, multicentre, phase 3 trial. , 2021, The Lancet. Haematology.

[10]  P. Sorger,et al.  Temporal and spatial topography of cell proliferation in cancer , 2021, bioRxiv.

[11]  M. Keshtkar,et al.  Assessment of some factors of cellular and humoral immunity in radiology workers , 2021, Radiation and Environmental Biophysics.

[12]  Yuchen Yang,et al.  Direct cell reprogramming: approaches, mechanisms and progress , 2021, Nature Reviews Molecular Cell Biology.

[13]  Nurhan Özlü,et al.  AF10 (MLLT10) prevents somatic cell reprogramming through regulation of DOT1L-mediated H3K79 methylation , 2020, bioRxiv.

[14]  Yuwen Li,et al.  Targeted disruption of the histone lysine 79 methyltransferase Dot1L in nephron progenitors causes congenital renal dysplasia , 2020, Epigenetics.

[15]  A. Zhang,et al.  The emerging role of MEIS1 in cell proliferation and differentiation. , 2020, American journal of physiology. Cell physiology.

[16]  J. Ng,et al.  The Methyltransferase DOT1L Controls Activation and Lineage Integrity in CD4+ T Cells during Infection and Inflammation. , 2020, Cell reports.

[17]  Egidio D’Angelo,et al.  Cerebellar Granule Cell , 2020, Handbook of the Cerebellum and Cerebellar Disorders.

[18]  F. Ferrari,et al.  DOT1L-mediated murine neuronal differentiation associates with H3K79me2 accumulation and preserves SOX2-enhancer accessibility , 2020, Nature Communications.

[19]  Mihai I Truica,et al.  Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer , 2020, Nature Communications.

[20]  H. Xie,et al.  Specific patterns of H3K79 methylation influence genetic interaction of oncogenes in AML. , 2020, Blood advances.

[21]  K. Kent,et al.  Nullifying epigenetic writer DOT1L attenuates neointimal hyperplasia. , 2020, Atherosclerosis.

[22]  M. Czech.  Mechanisms of insulin resistance related to white, beige, and brown adipocytes , 2020, Molecular metabolism.

[23]  Xiuzhen Huang,et al.  A genetic system for tissue-specific inhibition of cell proliferation , 2020, Development.

[24]  M. Domowicz,et al.  The Role of Dot1l in Prenatal and Postnatal Murine Chondrocytes and Trabecular Bone , 2019, JBMR plus.

[25]  L. Marcos-Villar,et al.  The DOT1L inhibitor Pinometostat decreases the host-response against infections: Considerations about its use in human therapy , 2019, Scientific Reports.

[26]  A. Weisz,et al.  The Histone Methyltransferase DOT1L Is a Functional Component of Estrogen Receptor Alpha Signaling in Ovarian Cancer Cells , 2019, Cancers.

[27]  K. Rajewsky,et al.  Histone methyltransferase DOT1L controls state‐specific identity during B cell differentiation , 2019, bioRxiv.

[28]  J. G. Patton,et al.  The miR-216a-Dot1l Regulatory Axis Is Necessary and Sufficient for Müller Glia Reprogramming during Retina Regeneration , 2019, Cell reports.

[29]  Sydney M. Shaffer,et al.  Genetic screening for single-cell variability modulators driving therapy resistance , 2019, bioRxiv.

[30]  L. Milanesi,et al.  Inhibition of histone methyltransferase DOT1L silences ERα gene and blocks proliferation of antiestrogen-resistant breast cancer cells , 2019, Science Advances.

[31]  G. Ossenkoppele.  Acute myeloid leukemia , 2018, Methods in Molecular Biology.

[32]  Mohsin Bashir,et al.  Transcriptional activator DOT1L putatively regulates human embryonic stem cell differentiation into the cardiac lineage , 2018, Stem Cell Research & Therapy.

[33]  Yanpan Gao,et al.  The histone methyltransferase DOT1L inhibits osteoclastogenesis and protects against osteoporosis , 2018, Cell Death & Disease.

[34]  R. C. Poulos,et al.  The Histone Methyltransferase DOT1L Promotes Neuroblastoma by Regulating Gene Transcription. , 2017, Cancer research.

[35]  Q. Nie,et al.  MiR-34b-5p Suppresses Melanoma Differentiation-Associated Gene 5 (MDA5) Signaling Pathway to Promote Avian Leukosis Virus Subgroup J (ALV-J)-Infected Cells Proliferaction and ALV-J Replication , 2017, Front. Cell. Infect. Microbiol..

[36]  N. Hellbach,et al.  DOT1L Activity Promotes Proliferation and Protects Cortical Neural Stem Cells from Activation of ATF4‐DDIT3‐Mediated ER Stress In Vitro , 2016, Stem cells.

[37]  E. Olhava,et al.  DOT1L Inhibitor EPZ-5676 Displays Synergistic Antiproliferative Activity in Combination with Standard of Care Drugs and Hypomethylating Agents in MLL-Rearranged Leukemia Cells , 2014, The Journal of Pharmacology and Experimental Therapeutics.

[38]  F. Aoki,et al.  Involvement of DOT1L in the Remodeling of Heterochromatin Configuration During Early Preimplantation Development in Mice1 , 2013, Biology of reproduction.

[39]  S. Armstrong,et al.  Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor. , 2011, Cancer cell.

[40]  Caroline M. Jakuba,et al.  ES Cell Cycle Progression and Differentiation Require the Action of the Histone Methyltransferase Dot1L , 2009, Stem cells.

[41]  E. Li,et al.  The Histone H3K79 Methyltransferase Dot1L Is Essential for Mammalian Development and Heterochromatin Structure , 2008, PLoS genetics.

[42]  M. Fornerod,et al.  Nonprocessive methylation by Dot1 leads to functional redundancy of histone H3K79 methylation states , 2008, Nature Structural &Molecular Biology.

[43]  David Lydall,et al.  Histone methyltransferase Dot1 and Rad9 inhibit single-stranded DNA accumulation at DSBs and uncapped telomeres , 2008, The EMBO journal.

[44]  S. Kageyama,et al.  Changes in H3K79 Methylation During Preimplantation Development in Mice , 2008, Biology of reproduction.

[45]  Yi Zhang,et al.  hDOT1L Links Histone Methylation to Leukemogenesis , 2005, Cell.

[46]  Yi Zhang,et al.  Structure of the Catalytic Domain of Human DOT1L, a Non-SET Domain Nucleosomal Histone Methyltransferase , 2003, Cell.

[47]  M. Johnston,et al.  The Paf1 complex is required for histone H3 methylation by COMPASS and Dot1p: linking transcriptional elongation to histone methylation. , 2003, Molecular cell.

[48]  Philip R. Gafken,et al.  Dot1p Modulates Silencing in Yeast by Methylation of the Nucleosome Core , 2002, Cell.

[49]  D. Gottschling,et al.  Identification of high-copy disruptors of telomeric silencing in Saccharomyces cerevisiae. , 1998, Genetics.

[50]  L. Krishnan,et al.  Introduction to the immune system. , 2013, Methods in molecular biology.

[51]  broader , 2022, Birth….